Outsourcing STREAM
-
Early Phase Clinical Development Solutions
1/30/2023
Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.
-
An Innovative Approach To Functional Outsourcing
8/27/2025
The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.
-
See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada
3/23/2023
Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.
-
How Sponsors Turn Disclosure As A Service Into A Strategic Advantage
5/18/2020
In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.
-
Big Impact With A Personal Touch
1/30/2023
Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
Outsourcing Clinical Trial Disclosure Management
6/3/2020
Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.
-
Streamlining Patient Access To Cell And Gene Therapies
12/21/2023
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
The Path Forward, Altasciences' Approach To Project Management
3/19/2024
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
-
Altasciences Clinical Services At A Glance
1/30/2023
We can support your entire drug development program end to end, or you can partner with us for just one element. We offer you complete flexibility.